Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. more
Time Frame | NYXH | Sector | S&P500 |
---|---|---|---|
1-Week Return | 0.27% | -3.39% | 0.2% |
1-Month Return | -2.32% | -1.92% | 2.72% |
3-Month Return | -4.06% | -10.54% | 7.31% |
6-Month Return | -6.44% | -4.47% | 10.44% |
1-Year Return | 60.76% | 4.06% | 27.53% |
3-Year Return | -59.44% | 0.94% | 30.88% |
5-Year Return | -66.71% | 36.67% | 89.21% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | 69.00K | 852.00K | 3.08M | 4.35M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":1.59,"profit":true},{"date":"2021-12-31","value":19.6,"profit":true},{"date":"2022-12-31","value":70.93,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 433.00K | 30.00K | 303.00K | 1.15M | 1.66M | [{"date":"2019-12-31","value":26.15,"profit":true},{"date":"2020-12-31","value":1.81,"profit":true},{"date":"2021-12-31","value":18.3,"profit":true},{"date":"2022-12-31","value":69.44,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (433.00K) | 39.00K | 549.00K | 1.93M | 2.69M | [{"date":"2019-12-31","value":-16.08,"profit":false},{"date":"2020-12-31","value":1.45,"profit":true},{"date":"2021-12-31","value":20.39,"profit":true},{"date":"2022-12-31","value":71.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | - | 56.52% | 64.44% | 62.71% | 61.91% | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":87.72,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.32,"profit":true},{"date":"2023-12-31","value":96.08,"profit":true}] |
Operating Expenses | 6.52M | 11.26M | 26.79M | 34.43M | 47.79M | [{"date":"2019-12-31","value":13.63,"profit":true},{"date":"2020-12-31","value":23.57,"profit":true},{"date":"2021-12-31","value":56.06,"profit":true},{"date":"2022-12-31","value":72.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (6.52M) | (11.22M) | (26.24M) | (32.50M) | (45.10M) | [{"date":"2019-12-31","value":-651600000,"profit":false},{"date":"2020-12-31","value":-1122400000,"profit":false},{"date":"2021-12-31","value":-2624200000,"profit":false},{"date":"2022-12-31","value":-3249900000,"profit":false},{"date":"2023-12-31","value":-4510200000,"profit":false}] |
Total Non-Operating Income/Expense | (1.29M) | (1.90M) | 6.00K | 4.89M | 1.50M | [{"date":"2019-12-31","value":-26.32,"profit":false},{"date":"2020-12-31","value":-38.78,"profit":false},{"date":"2021-12-31","value":0.12,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":30.68,"profit":true}] |
Pre-Tax Income | (7.18M) | (12.15M) | (24.64M) | (30.06M) | (44.66M) | [{"date":"2019-12-31","value":-718500000,"profit":false},{"date":"2020-12-31","value":-1215200000,"profit":false},{"date":"2021-12-31","value":-2463900000,"profit":false},{"date":"2022-12-31","value":-3005600000,"profit":false},{"date":"2023-12-31","value":-4465700000,"profit":false}] |
Income Taxes | 70.00K | 93.00K | 2.98M | 1.17M | (1.45M) | [{"date":"2019-12-31","value":2.35,"profit":true},{"date":"2020-12-31","value":3.12,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":39.23,"profit":true},{"date":"2023-12-31","value":-48.49,"profit":false}] |
Income After Taxes | (7.25M) | (12.24M) | (27.62M) | (31.23M) | (43.21M) | [{"date":"2019-12-31","value":-725500000,"profit":false},{"date":"2020-12-31","value":-1224500000,"profit":false},{"date":"2021-12-31","value":-2761900000,"profit":false},{"date":"2022-12-31","value":-3122500000,"profit":false},{"date":"2023-12-31","value":-4321200000,"profit":false}] |
Income From Continuous Operations | (7.25M) | (12.24M) | (27.62M) | (31.23M) | (45.62M) | [{"date":"2019-12-31","value":-725500000,"profit":false},{"date":"2020-12-31","value":-1224500000,"profit":false},{"date":"2021-12-31","value":-2761900000,"profit":false},{"date":"2022-12-31","value":-3122500000,"profit":false},{"date":"2023-12-31","value":-4561500000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (7.25M) | (12.24M) | (27.62M) | (31.23M) | (43.21M) | [{"date":"2019-12-31","value":-725500000,"profit":false},{"date":"2020-12-31","value":-1224500000,"profit":false},{"date":"2021-12-31","value":-2761900000,"profit":false},{"date":"2022-12-31","value":-3122500000,"profit":false},{"date":"2023-12-31","value":-4321200000,"profit":false}] |
EPS (Diluted) | (0.33) | (0.80) | (1.17) | (1.20) | (1.56) | [{"date":"2019-12-31","value":-32.72,"profit":false},{"date":"2020-12-31","value":-80.15,"profit":false},{"date":"2021-12-31","value":-116.85,"profit":false},{"date":"2022-12-31","value":-120,"profit":false},{"date":"2023-12-31","value":-156,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
NYXH | |
---|---|
Cash Ratio | 4.49 |
Current Ratio | 5.28 |
Quick Ratio | 4.95 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
NYXH | |
---|---|
ROA (LTM) | -23.14% |
ROE (LTM) | -49.69% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
NYXH | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.27 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.73 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
NYXH | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 60.01 |
P/B | 2.72 |
Price/FCF | NM |
EV/R | 47.92 |
EV/Ebitda | NM |
Nyxoah (NYXH) share price today is $7.96
Yes, Indians can buy shares of Nyxoah (NYXH) on Vested. To buy Nyxoah from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NYXH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Nyxoah (NYXH) via the Vested app. You can start investing in Nyxoah (NYXH) with a minimum investment of $1.
You can invest in shares of Nyxoah (NYXH) via Vested in three simple steps:
The 52-week high price of Nyxoah (NYXH) is $20. The 52-week low price of Nyxoah (NYXH) is $4.
The price-to-earnings (P/E) ratio of Nyxoah (NYXH) is
The price-to-book (P/B) ratio of Nyxoah (NYXH) is 2.72
The dividend yield of Nyxoah (NYXH) is 0.00%
The market capitalization of Nyxoah (NYXH) is $304.95M
The stock symbol (or ticker) of Nyxoah is NYXH